NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
49 hedge funds and large institutions have $51.5M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+24
Holders Change %
+96%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
12
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$8.19M |
| 2 |
2
Renaissance Technologies
New York
|
$7.87M |
| 3 |
3
Millennium Management
New York
|
$3.68M |
| 4 |
GC
4
Greenlight Capital
New York
|
$16.7M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$2.18M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$0 |
| 2 |
2
Squarepoint
New York
|
$0 |
| 3 |
EI
3
EAM Investors
Solana Beach,
California
|
$756K |
| 4 |
4
Jane Street
New York
|
$0 |
| 5 |
5
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
51
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$87K | -610 | Closed |
|
|
FIA
52
FNY Investment Advisers
New York
| – | -$80K | -564 | Closed |
|
53
Acadian Asset Management
Boston,
Massachusetts
| – | -$54K | -379 | Closed |
|